{"id":"NCT00863681","sponsor":"Bayer","briefTitle":"BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension","officialTitle":"Long-term Extension, Multicentre, Multi-national Study to Evaluate the Safety and Tolerability of Oral BAY63-2521 (1mg,1.5 mg, 2.0 mg, 2.5 mg Tid) in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03-12","primaryCompletion":"2019-08-19","completion":"2019-08-19","firstPosted":"2009-03-18","resultsPosted":"2020-10-22","lastUpdate":"2023-11-07"},"enrollment":396,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension, Pulmonary"],"interventions":[{"type":"DRUG","name":"Riociguat (BAY63-2521)","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"}],"summary":"Patients who have completed the 12 weeks treatment of the PATENT-1 trial (study number 12934) will be asked to participate in this long term extension study with BAY63-2521.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAE)","timeFrame":"From administration of first dose of study medication in PATENT-2 up to 2 days after end of treatment with study medication, up to 10 years and 5 months.","effectByArm":[{"arm":"Riociguat-Former Riociguat 1.0-2.5 mg","deltaMin":229,"sd":null},{"arm":"Riociguat-Former Placebo","deltaMin":108,"sd":null},{"arm":"Riociguat-Former Riociguat 1.0-1.5 mg","deltaMin":56,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":99,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","China","Czechia","Denmark","France","Germany","Greece","Italy","Japan","Mexico","Poland","Portugal","Russia","Singapore","South Korea","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["34848133","35256218","27067479","27263466","34353714","27457511","27162632","26135803","25614164","23883378"],"seeAlso":["http://www.clinicaltrialsregister.eu/","http://clinicaltrials.bayer.com/"]},"adverseEventsSummary":{"seriousAny":{"events":161,"n":231},"commonTop":["Nasopharyngitis","Dizziness","Oedema peripheral","Cough","Diarrhoea"]}}